AJP - Renal Add DOIs to your references at manuscript stage!
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Renal Physiol 295: F932-F941, 2008. First published July 16, 2008; doi:10.1152/ajprenal.00066.2008
0363-6127/08 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
295/4/F932    most recent
00066.2008v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhou, Z.
Right arrow Articles by Schrier, R. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhou, Z.
Right arrow Articles by Schrier, R. W.

Role of NF-{kappa}B and PI 3-kinase/Akt in TNF-{alpha}-induced cytotoxicity in microvascular endothelial cells

Zhu Zhou,2 Patricia Gengaro,1 Wei Wang,1 Xue-qing Wang,1 Chunling Li,1 Sarah Faubel,1 Christopher Rivard,1 and Robert W. Schrier1

1Department of Medicine, University of Colorado at Denver and Health Sciences Center, Denver, Colorado; and 2First Affiliated Hospital of Kunming Medical College, Kunming, Yunnai, People's Republic of China

Submitted 6 February 2008 ; accepted in final form 10 July 2008

The interaction of tumor necrosis factor (TNF)-{alpha} with the endothelium is a pivotal factor during endotoxemia. Inflammatory conditions are characterized by the activation of the transcription factor NF-{kappa}B and the expression of inflammatory mediators. Previous reports indicate that inhibition of NF-{kappa}B activation during sepsis may be beneficial to the microvasculature. In addition, the phosphatidylinositol-3-kinase/Akt signaling pathway (PI3-kinase/Akt) has been shown to be cytoprotective. In this study, we examined the effect of inhibition of NF-{kappa}B and PI3-kinase/Akt on cell viability, cytokine production, inducible nitric oxide synthase (iNOS) expression, and nitric oxide (NO) generation by TNF-{alpha}-treated cultured microvascular endothelial cells. TNF-{alpha} induced significant cytotoxicity and was associated with increased inflammatory cytokines and NO and increased expression of iNOS. The NF-{kappa}B inhibitor, pyrrolidine dithiocarbamate (PDTC), prevented these increases and significantly attenuated the TNF-{alpha}-induced cytotoxicity. TNF-{alpha} also caused PI3-kinase/Akt activation, which was further increased by PDTC and prevented by the PI3-kinase inhibitor, LY294002. Inhibition of PI3-kinase/Akt also significantly potentiated TNF-{alpha}-mediated cytotoxicity. LY294002 treatment resulted in the appearance of increased apoptosis, compatible with the known anti-apoptotic properties of PI3-kinase/Akt. The present results therefore demonstrate a cytotoxic effect of TNF-{alpha} in microvascular endothelial cells which can be attenuated by NF-{kappa}B inhibition. In addition, PI3-kinase/Akt activation during TNF-{alpha} exposure may represent a compensatory anti-necrotic and anti-apoptotic pathway. The cytoprotective effects of NF-{kappa}B inhibition and PI3-kinase/Akt activation may have potential implications in the treatment of endotoxemia and septic shock.

endotoxemia; sepsis; cell culture; PDTC; LY294002



Address for reprint requests and other correspondence: R. W. Schrier, Univ. of Colorado Health Sciences Center, Box B173, 4200 E 9th Ave., Denver, CO 80262 (e-mail: robert.schrier{at}ucdenver.edu)




This article has been cited by other articles:


Home page
FASEB J.Home page
Y. Zhang, B.-S. Herbert, G. Rajashekhar, D. A. Ingram, M. C. Yoder, M. Clauss, and J. Rehman
Premature senescence of highly proliferative endothelial progenitor cells is induced by tumor necrosis factor-{alpha} via the p38 mitogen-activated protein kinase pathway
FASEB J, May 1, 2009; 23(5): 1358 - 1365.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2008 by the American Physiological Society.